An interventional study of different dual-task paradigms in Healthy Athlete, sponsored by Zurich University of Applied Sciences. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 34 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Zurich University of Applied Sciences · Not applicable, Interventional, and Basic science
The goal of this clinical trial is to provide a more specific understanding of which dual task conditions elicit changes in either motor or cognitive performance. A dual-task is a simultaneously performed motor and cognitive task. Exergaming describes physically active gaming. The main questions the study aims to answer are:
Participants will:
The two sessions last each approximately 2 hours and take place within one to 12 weeks. Both sessions involve measurement of biomechanical movement patterns with motion capture.
Zurich University of Applied Sciences is the lead sponsor of 23 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants are exposed to the same dual-task paradigms described in the intervention.
Other: different dual-task paradigms
Participants will perform combined motor-cognitive tasks. During the first session balancing and bilateral jumping will be combined with an additional auditory or visual cognitive task. During the second session participants will do a combined motor-cognitive task in exergaming.
Cognitive dual-task cost
Dual-task cost with the different modalities are operationalized by reaction time.
Time frame: Measurement session 1 (day 0) and session 2 (days 6-90)
Exergaming performance
Operationalized as task success rate
Time frame: Session 2 (days 6-90)
Motor dual-task cost
The motor dual-task costs are operationalized by the peak knee abduction angle.
Time frame: Session 1 (day 0)
Countermovement Jump
Height of a countermovement jump
Time frame: Session 1 (day 0) and session 2 (day 6-90)
ProAgility Test
Measured using the total elapsed time in the ProAgility Test.
Time frame: Session 1 (day 0) and session 2 (day 6-90)
Y-Balance Test
Measured using the composite reach distance in all directions of the Y-Balance Test.
Time frame: Session 1 (day 0) and session 2 (days 6-90)
Joint Angle
Angles of ankle, knee, and hip during the dual-tasks.
Time frame: Session 1 (day 0) and session 2 (day 6-90)
Joint Moment
Moments of ankle, knee, and hip during the dual-tasks.
Time frame: Session 1 (day 0) and session 2 (day 6-90)
Ground Reaction Force
Ground reaction force during the dual-tasks.
Time frame: Session 1 (day 0) and session 2 (day 6-90)
Center of pressure
Center of pressure during the dual-tasks.
Time frame: Session 1 (day 0) and session 2 (day 6-90)
Plan to share: Yes — Pooled data of participants will be shared on a repository if consent is given by the participants.
Time frame: Within one year after completion of the study.
Access criteria: The access conditions will be defined in the license statement adjacent to the dataset.
No publications or documents are linked to this record.
Ran from Mar 2026 to primary completion in Aug 2026, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zurich University of Applied Sciences